Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study evaluates Copaxone (glatiramer acetate) administered with N-acetylcysteine for Relapsing-Remitting Multiple Sclerosis; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapse Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED